HomeInsightsPE

Laurus Labs Ltd PE Ratio

Laurus Labs Ltd PE Ratio

stocks purchased

₹ 2.8 Cr

Volume transacted

stocks purchased

59.2 K

stocks traded

Last Updated time: 19 Sep 15:30 PM

Image

Laurus Labs Ltd

NSE: LAURUSLABS

PE

171

Last updated: 19 Sep 15:30 PM

Key Highlights

  • The P/E Ratio of Laurus Labs Ltd is 171 as of 19 Sep 15:30 PM.
  • The P/E Ratio of Laurus Labs Ltd changed from 45.4 on March 2019 to 131.5 on March 2024 . This represents a CAGR of 19.39% over 6 years. .
  • The Latest Trading Price of Laurus Labs Ltd is ₹ 470.2 as of 19 Sep 15:30.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 21.8. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.2. The PE Ratio of Retail industry is 164.1. The PE Ratio of Textiles industry is 35.8. In 2024.

Historical P/E Ratio of Laurus Labs Ltd

No data available

Company Fundamentals for Laurus Labs Ltd

No data available

Image

Laurus Labs Ltd

NSE: LAURUSLABS

PRICE

470.2

-14.70 (-3.03%)

stock direction

Last updated: 19 Sep 15:30

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Laurus Labs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
19 Sep 2024470.2
18 Sep 2024484.9
17 Sep 2024501.3
16 Sep 2024504.55
13 Sep 2024505.7
12 Sep 2024506.95
11 Sep 2024506.45
10 Sep 2024506.95
09 Sep 2024490.65
06 Sep 2024481.4

SWOT Analysis Of Laurus Labs Ltd

Strength

6

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Laurus Labs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Laurus Labs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Laurus Labs Ltd17025,351
Sun Pharmaceuticals Industries Ltd424,43,025
Divis Laboratories Ltd861,44,299
Cipla Ltd291,32,316
Torrent Pharmaceuticals Ltd671,13,396
Dr Reddys Laboratories Ltd191,08,579

Key Valuation Metric of Laurus Labs Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Laurus Labs Ltd

No data available

* All values are in crore

Historical Revenue of Laurus Labs Ltd

No data available

* All values are in crore

Historical EBITDA of Laurus Labs Ltd

No data available

* All values are in crore

Historical Net Profit of Laurus Labs Ltd

No data available

* All values are in crore

Historical Dividend Payout of Laurus Labs Ltd

No data available

* All values are in %

About Laurus Labs Ltd

  • Laurus Labs is a science-led, fully integrated pharmaceutical and biotechnology manufacturing company with a leadership position in generic active pharmaceutical ingredients (APIs) in selected high-growth therapeutic areas of anti-retrovirals (ARVs), Hepatitis C and Oncology.
  • The company also manufactures APIs in oncology and other therapeutic areas, such as anti-asthma, ophthalmology, antidiabetics, cardiovascular, proton pump inhibitors (PPIs) amongst others.
  • The company currently operates 4 manufacturing facilities in Visakhapatnam, Andhra Pradesh.
  • Three of these facilities manufacture APIs and ingredients, while the fourth facility produces Finished Dosage Formulations (FDFs) and one API.
  • The company's strategic and early investments in R&D and manufacturing infrastructure has enabled it to become one of the leading suppliers of APIs in the ARV therapeutic area to multi-national pharmaceutical formulation companies which cater to the large and fast-growing 'donor-funded access-to-medicines markets' of Sub-Saharan Africa, South-East Asia and Latin America.

Laurus Labs Ltd News Hub

News

Laurus Labs Ltd drops for fifth straight session

Laurus Labs Ltd fell for a fifth straight session today. The stock is quoting at Rs 463.95...

Read more

19 Sep 202413:36

News

Laurus Labs inaugurates new R&D center at IKP Knowledge Park

Laurus Labs announced the inauguration of its state of the art new R&D center at IKP Knowl...

Read more

16 Sep 202415:32

News

Laurus Labs Hyderabad unit clears USFDA inspection

The pharmaceutical company said that its API manufacturing facility located at Hyderabad h...

Read more

14 Sep 202416:55

News

Laurus Labs Ltd up for third straight session

Laurus Labs Ltd is up for a third straight session today. The stock is quoting at Rs 512, ...

Read more

11 Sep 202413:06

News

Laurus Labs Ltd soars 4.39%

Laurus Labs Ltd is up for a third straight session in a row. The stock is quoting at Rs 49...

Read more

05 Sep 202413:05

News

Laurus Labs Ltd spurts 1.39%, up for five straight sessions

Laurus Labs Ltd rose for a fifth straight session today. The stock is quoting at Rs 443.5,...

Read more

21 Aug 202413:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Laurus Labs Ltd

What is the current PE Ratio of Laurus Labs Ltd?

The Current PE Ratio of Laurus Labs Ltd is 170.98 as on 19 Sep 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.2 as on 19 Sep 2024.

What was the PE Ratio of Laurus Labs Ltd last year?

The PE Ratio of Laurus Labs Ltd was 19.97 last year, now the PE ratio is 170.98, showing a year-on-year growth of 756.2%.

What does the PE Ratio of Laurus Labs Ltd indicate about its stock?

The PE Ratio of Laurus Labs Ltd is 170.98. This ratio indicates that investors are willing to pay 170.98 times the earnings per share for each share of Laurus Labs Ltd.

What is the PE Ratio Growth of Laurus Labs Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Laurus Labs Ltd grew by 756.2% whereas, the EPS ratio grew by -83.6.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*